Long-term follow-up of a prospective randomized trial comparing CYA and MTX with CYA and mycophenolate mofetil for GVHD prophylaxis in myeloablative sibling donor hematopoietic cell transplantation

Bone Marrow Transplant. 2013 Nov;48(12):1578-80. doi: 10.1038/bmt.2013.89. Epub 2013 Jun 10.

Authors

B K Hamilton¹, B Bolwell, M Kalaycio, L Rybicki, R Hanna, R Sobecks, B Pohlman, S Andresen, R Dean, H Duong, B Hill, E Copelan

Affiliation

¹ Bone Marrow Transplant Program, Department of Hematologic Oncology and Blood Disorders, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA.

PMID: 23749105
DOI: 10.1038/bmt.2013.89

No abstract available

Publication types

Letter
Randomized Controlled Trial

MeSH terms

Adult
Cyclosporine / adverse effects
Cyclosporine / therapeutic use*
Female
Follow-Up Studies
Graft vs Host Disease / prevention & control*
Hematopoietic Stem Cell Transplantation / adverse effects
Hematopoietic Stem Cell Transplantation / methods*
Humans
Immunosuppressive Agents / adverse effects
Immunosuppressive Agents / therapeutic use*
Male
Methotrexate / adverse effects
Methotrexate / therapeutic use*
Middle Aged
Mycophenolic Acid / adverse effects
Mycophenolic Acid / analogs & derivatives*
Mycophenolic Acid / therapeutic use
Prospective Studies
Siblings
Tissue Donors
Transplantation Conditioning / adverse effects
Transplantation Conditioning / methods
Transplantation, Autologous
Young Adult

Substances

Immunosuppressive Agents
Cyclosporine
Mycophenolic Acid
Methotrexate